Imagion Biosystems Limited (ASX: IBX) has lodged “Appendix 3B: New issue announcement, application for quotation of additional securities and agreement” with the Australian Securities Exchange.View “Appendix 3B: New issue announcement”
Imagion Initiates Collaboration with Wayne State University to Develop Advanced Molecular Imaging Capabilities to Enable AI Cancer Diagnostics
August 13, 2025
Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilizing its proprietary MagSense® imaging